| ethinyl estradiol/norgestimate / Generic mfg. |
NCT00357604: Atazanavir and Ritonavir (ATV/RTV) and an Oral Contraceptive in Healthy Females |
|
|
| Completed | 1 | 22 | US | Ortho Tri-Cyclen (ethinyl estradiol + norgestimate), Ortho Tri-Cyclen LO (ethinyl estradiol + norgestimate) + Atazanavir/Ritonavir for 14 days then Ortho Tri-Cyclen for 7 days, Reyataz | Bristol-Myers Squibb | HIV Infections | 11/06 | 11/06 | | |
| Completed | 1 | 28 | US | Ortho Tri-Cyclen LO, Ortho Cyclen, Ortho Cyclen + Efavirenz, Sustiva | Bristol-Myers Squibb | HIV Infections | 08/07 | 08/07 | | |
NCT00983957: Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects |
|
|
| Completed | 1 | 47 | US, Canada | BMS-790052, Ortho Tri-Cyclen® | Bristol-Myers Squibb | Chronic Hepatitis C | 02/10 | 02/10 | | |
|
| Completed | 1 | 20 | US | Ortho Tri-Cyclen®, BMS-650032 | Bristol-Myers Squibb | Hepatitis C Virus | 06/10 | 06/10 | | |
NCT01498861: Drug Interaction Study Between Dolutegravir and an Oral Contraceptive Containing Norgestimate and Ethinylestradiol |
|
|
| Completed | 1 | 16 | US | Ortho-Cyclen, Dolutegravir, GSK1349572, Placebo | ViiV Healthcare, Shionogi, GlaxoSmithKline | Infection, Human Immunodeficiency Virus | 03/12 | 03/12 | | |
